1. Home
  2. PHGE vs TKLF Comparison

PHGE vs TKLF Comparison

Compare PHGE & TKLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PHGE
  • TKLF
  • Stock Information
  • Founded
  • PHGE 2015
  • TKLF 2006
  • Country
  • PHGE Israel
  • TKLF Japan
  • Employees
  • PHGE N/A
  • TKLF N/A
  • Industry
  • PHGE Biotechnology: Pharmaceutical Preparations
  • TKLF Other Specialty Stores
  • Sector
  • PHGE Health Care
  • TKLF Consumer Discretionary
  • Exchange
  • PHGE Nasdaq
  • TKLF Nasdaq
  • Market Cap
  • PHGE 13.3M
  • TKLF 15.7M
  • IPO Year
  • PHGE N/A
  • TKLF 2022
  • Fundamental
  • Price
  • PHGE $0.59
  • TKLF $3.16
  • Analyst Decision
  • PHGE Strong Buy
  • TKLF
  • Analyst Count
  • PHGE 2
  • TKLF 0
  • Target Price
  • PHGE $23.00
  • TKLF N/A
  • AVG Volume (30 Days)
  • PHGE 200.7K
  • TKLF 16.3K
  • Earning Date
  • PHGE 05-19-2025
  • TKLF 12-18-2024
  • Dividend Yield
  • PHGE N/A
  • TKLF N/A
  • EPS Growth
  • PHGE N/A
  • TKLF N/A
  • EPS
  • PHGE N/A
  • TKLF 1.70
  • Revenue
  • PHGE N/A
  • TKLF $219,520,631.00
  • Revenue This Year
  • PHGE N/A
  • TKLF N/A
  • Revenue Next Year
  • PHGE N/A
  • TKLF N/A
  • P/E Ratio
  • PHGE N/A
  • TKLF $1.81
  • Revenue Growth
  • PHGE N/A
  • TKLF 32.02
  • 52 Week Low
  • PHGE $0.48
  • TKLF $2.00
  • 52 Week High
  • PHGE $4.99
  • TKLF $8.53
  • Technical
  • Relative Strength Index (RSI)
  • PHGE 51.14
  • TKLF 46.96
  • Support Level
  • PHGE $0.52
  • TKLF $2.94
  • Resistance Level
  • PHGE $0.57
  • TKLF $3.30
  • Average True Range (ATR)
  • PHGE 0.05
  • TKLF 0.24
  • MACD
  • PHGE 0.01
  • TKLF 0.02
  • Stochastic Oscillator
  • PHGE 62.83
  • TKLF 72.55

About PHGE BiomX Inc. COmmon Stock

BiomX Inc is a clinical-stage microbiome company based in Israel. The company is engaged in developing both natural and engineered phage cocktails designed to target and destroy harmful bacteria that affect the appearance of the skin, as well as harmful bacteria in chronic diseases, such as inflammatory bowel disease, colorectal cancer, and primary sclerosing cholangitis. BX004 is its therapeutic phage product candidate under development for chronic pulmonary infections caused by Pseudomonas aeruginosa, or P. aeruginosa, a main contributor to morbidity and mortality in patients with CF.

About TKLF Yoshitsu Co. Ltd

Tokyo Lifestyle Co Ltd, formerly Yoshitsu Co Ltd is a retailer and wholesaler of Japanese beauty and health products, as well as other products. Its products include cosmetics, skincare, fragrance, and body care. The company's segment includes Directly-Operated Physical Stores; Online Stores and Services; and Franchise Stores and Wholesale Customers. The company generates maximum revenue from the Franchise Stores and Wholesale Customers segment. Geographically, the company generates maximum revenue from China followed by Japan and other overseas markets.

Share on Social Networks: